Pomegranate Extract for Health & Longevity - Quick Reference Sheet

Pomegranate Extract for Health & Longevity

Created on 07/08/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Pomegranate extract is an inexpensive, well-tolerated source of plant polyphenols. Its best-supported effect is modestly lowering blood pressure, with fairly consistent gains in blood-vessel function, inflammation, and oxidative stress. Cholesterol and blood-sugar effects are mixed. The much-discussed cellular-energy benefits depend on gut bacteria that vary between people. Main drawbacks: mild digestive upset and added blood-pressure lowering. (Full Review)

Protocol

Dose
250–1000 mg/day
Extract standardized to punicalagins (~30%)
Timing
Once daily with food
A meal reduces digestive upset; single daily dose sufficient
Form
Extract or purified urolithin A
Purified urolithin A 500–1000 mg/day bypasses gut-conversion differences
Time to effect
Blood Pressure
4–8 weeks
Most consistent cardiovascular effect
Inflammation & Lipids
4–8 weeks
Develops alongside oxidative-stress markers
Muscle & Mitochondria
Months
Urolithin A–mediated; slower to appear

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Known pomegranate or tannin allergy
  • Clinically low blood pressure
  • Scheduled surgery within ~2 weeks
Key Interactions
  • Antihypertensive drugs (ACE inhibitors, ARBs, calcium-channel blockers)
  • Warfarin and other anticoagulants
  • Statins metabolized by CYP3A4 (simvastatin, atorvastatin, lovastatin)
  • Other CYP2C9 substrates (glipizide, phenytoin)
  • Over-the-counter medications (NSAIDs: ibuprofen, naproxen)
  • Blood-pressure-lowering supplements (beetroot/nitrate, garlic, coenzyme Q10, fish oil)

Risk & Side Effects

  • High: [risks_high]
  • Medium: Gastrointestinal discomfort; additive blood-pressure lowering
  • Low: Drug interactions via liver-enzyme inhibition; allergic reactions
  • Speculative: Reduced non-heme iron and mineral absorption; high-dose hepatic effects

Monitoring

Marker Target Why
Blood pressure <120/80 mmHg Pomegranate's most consistent effect
hs-CRP <1.0 mg/L Tracks the anti-inflammatory effect
LDL-C <100 mg/dL (lower if high cardiovascular risk) Captures any lipid benefit
HbA1c / fasting glucose HbA1c <5.4%; fasting glucose 75–90 mg/dL Screens the metabolic effect
Oxidized LDL / PON1 activity (optional) Higher PON1 activity is favorable Reflects the antioxidant mechanism

Cadence: Baseline, 8–12 weeks after starting, then every 6–12 months

Qualitative Assessment

  • Daytime energy and perceived exercise recovery
  • Subjective cognitive clarity and memory
  • Exercise tolerance and endurance
  • General sense of wellbeing